Reuters logo
BRIEF-North China Pharmaceutical unit gets Certificate of Suitability to Monograph of European Pharmacopoeia
April 17, 2017 / 2:35 AM / 5 months ago

BRIEF-North China Pharmaceutical unit gets Certificate of Suitability to Monograph of European Pharmacopoeia

April 17(Reuters) - North China Pharmaceutical Co Ltd

* Says wholly owned unit received Certificate of Suitability to Monograph of European Pharmacopoeia, from European Directorate for Quality of Medicines & HealthCare, for AMOXICILLIN TRIHYDRATE

* Certificate valid for 5 years

Source text in Chinese:goo.gl/Mzidk2

Further company coverage: (Beijing Headline News)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below